Genetically modified human placenta-derived mesenchymal stem cells with FGF-2 and PDGF-BB enhance neovascularization in a model of hindlimb ischemia

Ischemic diseases represent a challenging worldwide health burden. The current study investigated the therapeutic potential of genetically modified human placenta-derived mesenchymal stem cells (hPDMSCs) with basic fibroblast growth factor (FGF2) and platelet-derived growth factor-BB (PDGF-BB) genes...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Med Rep
Main Authors: YIN, TAO, HE, SISI, SU, CHAO, CHEN, XIANCHENG, ZHANG, DONGMEI, WAN, YANG, YE, TINGHONG, SHEN, GUOBO, WANG, YONGSHENG, SHI, HUASHAN, YANG, LI, WEI, YUQUAN
Format: Artigo
Sprog:Inglês
Udgivet: D.A. Spandidos 2015
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4581748/
https://ncbi.nlm.nih.gov/pubmed/26239842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2015.4089
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker